Guidelines

AAN calls oral cannabinoids effective for MS pain, spasticity

Publish date: March 24, 2014

 

FROM NEUROLOGY

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Stem cell transplantation effective in aggressive relapsing-remitting MS
MDedge Neurology
Obesity at Age 20 Is Associated With an Increased Risk for MS
MDedge Neurology
Teriflunomide Reduces Annual MS Relapse Rate
MDedge Neurology
Maintenance percutaneous tibial nerve stimulation improved bladder symptoms in MS
MDedge Neurology
MS relapse rates higher with 2-month washout before switch to fingolimod
MDedge Neurology
Results finally published for failed MS trial with B-cell targeting drug atacicept
MDedge Neurology
FDA extends review of pegylated interferon for MS, Biogen says
MDedge Neurology
Pseudobulbar affect: More common than you’d think
MDedge Neurology
Autoimmune disease coalition seeks to increase physician knowledge
MDedge Neurology
Simvastatin slows brain atrophy in secondary progressive multiple sclerosis
MDedge Neurology